FFA
IRWD icon

Farther Finance Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Farther Finance Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Sell
395
-1,140
-74% -$4.39K ﹤0.01% 5222
2026
Q1 		$5.99K Buy
1,535
+1,483
+2,852% +$6.08K ﹤0.01% 4398
2025
Q4 		$175 Buy
+52
New +$135 ﹤0.01% 5230
2025
Q2 		– Sell
-82
Closed -$116 – 4581
2025
Q1 		$116 Hold
82
– – ﹤0.01% 4048
2024
Q4 		$363 Hold
82
– – ﹤0.01% 3509
2024
Q3 		$338 Sell
82
-131
-62% -$704 ﹤0.01% 3522
2024
Q2 		$1.39K Buy
213
+128
+151% +$905 ﹤0.01% 2945
2024
Q1 		$732 Hold
85
– – ﹤0.01% 2896
2023
Q4 		$972 Sell
85
-95
-53% -$940 ﹤0.01% 2744
2023
Q3 		$1.73K Sell
180
-28
-13% -$274 ﹤0.01% 1910
2023
Q2 		$2.21K Buy
208
+28
+16% +$301 ﹤0.01% 1719
2023
Q1 		$1.89K Hold
180
– – ﹤0.01% 1662
2022
Q4 		$2.23K Buy
+180
New +$2.04K ﹤0.01% 1413

Other funds holding IRWD

WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
RFG
Range Financial Group Tigard, Oregon $366M AUM 76.17% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's IRWD Position: Q2 2026 in Review

Farther Finance Advisors reduced its Ironwood Pharmaceuticals (IRWD) stake by 74% in Q2 2026, selling an estimated $4.39K and leaving 395 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #5222.

Farther Finance Advisors first reported a position in IRWD in Q4 2022 and has held it in 13 quarters since. The position peaked at $5.99K in Q1 2026. 14 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Farther Finance Advisors held 395 shares of Ironwood Pharmaceuticals worth $1.67K as of Q2 2026.
  • Farther Finance Advisors sold 1,140 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $4.39K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5222 holding.
  • Farther Finance Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
  • Farther Finance Advisors's Ironwood Pharmaceuticals position peaked at $5.99K in Q1 2026.
  • 14 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.